Unlike Pfizer and Moderna, whose Covid-19 vaccines are based on new (mRNA) technology, all of Cuba’s five domestically produced vaccines are based on technology that has been used with children for decades. Back in 1988, Cuba’s Finlay Institute developed the world’s first Meningitis B vaccine, after an epidemic which particularly affected children. Soberana 2 increases immunogenicity and induces immunological memory. Children are being given two doses of Soberana 2 and a third of Soberana Plus at 28-day intervals. Cuban schools will not reopen until children have been vaccinated. By mid-September, 460,000 Cuban children and adolescents (20%) had received a first dose. More
The post Cuba Accelerates Vaccine Drive appeared first on CounterPunch.org.
This content originally appeared on CounterPunch.org and was authored by Helen Yaffe.